go to contents

Akribes Biomedical GmbH

Back to list

Facts

Founded
Staff
5
Organization type
RDM medtech

Profile

Development of a new pharmacological treatment for chronic wounds, identified by implementation of the first assay platform for personalized medicine of chronic wounds. The proprietary assays combine diagnosis and therapy recommendations for individual chronic wound patients. A Ph1b/2a proof-of-concept study is planned for 2025.

Similar companies in RDM medtech

Bucinator e. U.

Organization type
RDM medtech
Region
Tyrol
Topic
hospital hardware
telemedicine and e-health
software for medicine
Details

Novotech Medizinprodukte GmbH

Organization type
RDM medtech
Region
Styria
Topic
dental devices
Details

W&H

Organization type
RDM medtech
Region
Salzburg
Cluster
Medical Technology Cluster
Topic
dental devices
single-use devices
resuable devices
Details

P+F Products + Features GmbH

Organization type
RDM medtech
Region
Vienna
Cluster
LISAvienna
Topic
non-active implantable devices
Details

Contact



Contact: